NIH Tetramer Core Facility
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIAID
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N93026R00006
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
AN11
Additional Details
Documents2
The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), has issued a solicitation (Procurement Identifier: 75N93026R00006) for the NIH Tetramer Core Facility. This procurement seeks to engage qualified organizations in the field of biotechnology research and development, as classified under NAICS code 541714 (Research and Development in Biotechnology, except Nanobiotechnology). The opportunity is currently active and is not subject to any set-aside restrictions, making it open to all capable entities regardless of business size or socioeconomic status.
The primary objective of this solicitation is to support the NIH Tetramer Core Facility, which plays a critical role in advancing immunological research by providing specialized reagents and services. While the detailed scope and requirements are outlined in the attached solicitation PDF and Amendment #1, the core facility is expected to deliver high-quality, reliable research support in the area of biotechnology, with a focus on facilitating cutting-edge scientific investigations. Contractors are anticipated to contribute to the development, production, and distribution of tetramer reagents, which are essential tools for the identification and analysis of antigen-specific T cells in various research applications.
The contracting activity is managed by the NIH NIAID Office, under the Department of Health and Human Services. Interested parties should note that the procurement is classified under Product Service Code AN11, which pertains to research and development in the life sciences. The solicitation is posted on SAM.gov (Opportunity ID: 8e5a0f9841a64a9eb599181c48f070c3), where all official documents and amendments are available for review.
Key contacts for this opportunity include Zachary Fetters ([email protected], 240-236-9291) as the primary point of contact, and Ashley Kinderdine ([email protected], 240-669-5154) as the secondary contact. The solicitation was posted on May 22, 2026, with responses due by June 22, 2026.
Contractors considering this opportunity should have demonstrated expertise in biotechnology research and development, particularly in the production and quality assurance of immunological reagents. The successful contractor will be expected to maintain rigorous scientific standards and support the NIH’s mission to advance public health through innovative research. All interested parties are encouraged to review the full solicitation and amendment documents for comprehensive requirements and submission instructions.